[Featured Stock] JinMatrix Rises on Government's Push to Import UK COVID-19 Vaccine

[Asia Economy Reporter Minwoo Lee] Jin Matrix's stock price is on the rise. The news that the government is pushing to import the United Kingdom's novel coronavirus (COVID-19) vaccine has highlighted the fact that it has invested in related companies.

As of 9:35 a.m. on the 5th, Jin Matrix's stock price recorded 15,000 won, up 5.65% from the previous day. Around 9:08 a.m., it rose more than 10% to 15,750 won.

The news that the government is negotiating special import arrangements with the British pharmaceutical company AstraZeneca to import the vaccine from the University of Oxford's Jenner Institute in the future appears to have acted as a positive factor. Previously, Jin Matrix invested 4 million pounds (about 5.7 billion won) in 2018 in Vaxcyte, a spin-off from the University of Oxford. Professor Adrian Hill, the founder and board member of Vaxcyte, is the director of the Jenner Institute and is actively conducting clinical research with multinational pharmaceutical companies.